PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium Tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection
Overview
Authors
Affiliations
HIV co-infection is an important risk factor for tuberculosis (TB) providing a powerful model in which to dissect out defective, protective and dysfunctional Mycobacterium tuberculosis (MTB)-specific immune responses. To identify the changes induced by HIV co-infection we compared MTB-specific CD4+ responses in subjects with active TB and latent TB infection (LTBI), with and without HIV co-infection. CD4+ T-cell subsets producing interferon-gamma (IFN-γ), interleukin-2 (IL-2) and tumour necrosis factor-alpha (TNF-α) and expressing CD279 (PD-1) were measured using polychromatic flow-cytometry. HIV-TB co-infection was consistently and independently associated with a reduced frequency of CD4+ IFN-γ and IL-2-dual secreting T-cells and the proportion correlated inversely with HIV viral load (VL). The impact of HIV co-infection on this key MTB-specific T-cell subset identifies them as a potential correlate of mycobacterial immune containment. The percentage of MTB-specific IFN-γ-secreting T-cell subsets that expressed PD-1 was increased in active TB with HIV co-infection and correlated with VL. This identifies a novel correlate of dysregulated immunity to MTB, which may in part explain the paucity of inflammatory response in the face of mycobacterial dissemination that characterizes active TB with HIV co-infection.
Advances in the Diagnosis of Latent Tuberculosis Infection.
Zhang H, Guan W, Zhou J Infect Drug Resist. 2025; 18:483-493.
PMID: 39882252 PMC: 11776534. DOI: 10.2147/IDR.S504632.
Identification of cytokine signatures in HIV‑infected individuals with and without co‑infection.
Indrati A, Sumarpo A, Haryanto J, Rosmiati N, Munaya S, Turbawaty D Biomed Rep. 2024; 21(3):131.
PMID: 39070110 PMC: 11273192. DOI: 10.3892/br.2024.1819.
Larson E, Ellis A, Rodgers M, Gubernat A, Gleim J, Moriarty R Infect Immun. 2023; 91(5):e0055822.
PMID: 37039653 PMC: 10187125. DOI: 10.1128/iai.00558-22.
Immune checkpoint molecules in prevention and development of asthma.
Kanannejad Z, Soleimanian S, Ghahramani Z, Sepahi N, Mohkam M, Alyasin S Front Immunol. 2023; 14:1070779.
PMID: 36865540 PMC: 9972681. DOI: 10.3389/fimmu.2023.1070779.
Singh S, Kumar K, Panda M, Srivastava A, Mishra A, Prajapati V Mol Divers. 2022; 27(2):729-751.
PMID: 35633442 DOI: 10.1007/s11030-022-10452-2.